| JYSB2100092 | 阿柏西普眼内注射溶液 | aflibercept | Injection | Biological Products | Supplementary Application | 2021-04-07 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | In Review | 2021-04-06 | view |
| JXHL2100111 | 屈螺酮炔雌醇片 (Ⅱ) | drospirenone;ethinylestradiol | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2021-04-02 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | In Review | 2021-04-02 | view |
| JYHZ2100068 | 瑞戈非尼片 | regorafenib | Tablet | Chemical Drugs | License Renew | 2021-04-01 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2021-08-17 | view |
| JYHZ2100035 | 钆喷酸葡胺注射液 | Dimeglnmine Gadopentetate | Injection | Chemical Drugs | License Renew | 2021-02-27 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2021-08-12 | view |
| JYHZ2100034 | 钆喷酸葡胺注射液 | Dimeglnmine Gadopentetate | Injection | Chemical Drugs | License Renew | 2021-02-27 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2021-08-12 | view |
| JYHZ2100032 | 钆喷酸葡胺注射液 | Dimeglnmine Gadopentetate | Injection | Chemical Drugs | License Renew | 2021-02-27 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2021-08-12 | view |
| JYHZ2100033 | 钆喷酸葡胺注射液 | Dimeglnmine Gadopentetate | Injection | Chemical Drugs | License Renew | 2021-02-27 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2021-08-12 | view |
| JYHZ2100037 | 钆喷酸葡胺注射液 | Dimeglnmine Gadopentetate | Injection | Chemical Drugs | License Renew | 2021-02-27 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2021-08-12 | view |
| JYHZ2100036 | 钆喷酸葡胺注射液 | Dimeglnmine Gadopentetate | Injection | Chemical Drugs | License Renew | 2021-02-27 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2021-08-12 | view |
| JXHB2100024 | BAY 2416964片 | BAY 2416964 | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-02-25 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | In Review | 2021-02-24 | view |
| JXHB2100023 | BAY 2416964片 | BAY 2416964 | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-02-25 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | In Review | 2021-02-24 | view |
| JXHB2100025 | BAY 2416964片 | BAY 2416964 | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-02-25 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | In Review | 2021-02-24 | view |
| JYHZ2100030 | 阿司匹林肠溶片 | Aspirin | Tablet | Chemical Drugs | License Renew | 2021-02-23 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2021-07-27 | view |
| JYHZ2100029 | 阿司匹林肠溶片 | Aspirin | Tablet | Chemical Drugs | License Renew | 2021-02-23 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2021-07-27 | view |
| CYHB2100150 | 复方对乙酰氨基酚片（Ⅱ） | Anhydrous Caffeine;paracetamol;propyphenazone | Tablet | Chemical Drugs(原6) | Supplementary Application | 2021-01-21 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2021-03-23 | view |
| JYHB2100084 | 碘普罗胺注射液 | iopromide | Injection | Chemical Drugs | Supplementary Application | 2021-01-21 | 拜耳医药保健有限公司广州分公司 | Bayer Healthcare Co Ltd Guangzhou Branch | Filed | 2021-01-28 | view |
| JYHB2002699 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs | Supplementary Application | 2020-12-29 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2021-03-17 | view |
| JYHB2002704 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs | Supplementary Application | 2020-12-28 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2021-03-17 | view |
| JYHB2002703 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs | Supplementary Application | 2020-12-28 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2021-03-17 | view |
| JYHB2002702 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs | Supplementary Application | 2020-12-28 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2021-03-17 | view |
